Intel and DigitalBridge Group have joined forces to establish Articul8 AI, an independent company specializing in delivering a comprehensive generative artificial intelligence (GenAI) platform for enterprise clients. The GenAI software platform offers robust AI capabilities while prioritizing security by keeping customer data, training, and inference within the enterprise security perimeter. It provides deployment options including cloud, on-premises, or hybrid solutions.
Articul8’s formation is based on the intellectual property and technology of Intel, with collaboration from both companies on identifying market opportunities and promoting GenAI adoption in the enterprise. Arun Subramaniyan, formerly vice president and general manager in Intel’s Data Center and AI Group, has been appointed as the CEO of Articul8.
DigitalBridge Ventures, the venture initiative of DigitalBridge, served as the lead investor for Articul8. Intel and other established venture investors, such as Fin Capital, Mindset Ventures, Communitas Capital, GiantLeap Capital, GS Futures, and Zain Group, have also taken equity stakes in the newly formed company.
Intel’s CEO, Pat Gelsinger, emphasized the strategic significance of Articul8, stating that the company is well-positioned to deliver tangible business outcomes in collaboration with Intel and its broader ecosystem of customers and partners.
Articul8’s GenAI software platform, optimized on Intel hardware architectures, offers speed, security, and cost-efficiency, facilitating large enterprise customers to scale and operationalize AI. The platform has seen initial deployment at Boston Consulting Group (BCG) and has expanded to high-security sectors with specific domain knowledge needs, including financial services, aerospace, semiconductors, and telecommunications.
DigitalBridge’s CEO, Marc Ganzi, highlighted the importance of integrating GenAI capabilities into global enterprises’ workflows and commended Articul8 for providing a scalable and easy-to-deploy GenAI software platform.
Rich Lesser, Global Chair of BCG, acknowledged the strategic importance of GenAI in their clients’ business strategy and needs. BCG has been collaborating with Articul8 since its incubation stage at Intel, deploying its products for multiple clients seeking production-ready platforms with rapid time to market.
As an independent company funded by industry investment, Articul8 is poised to accelerate its go-to-market strategy and expand its product offerings for the broader GenAI ecosystem.
